Oncoclínicas board member resigns, triggering full board re-election

Paulo Belém resigned from Oncoclínicas' board, forcing a new election of all board members due to the multiple voting system. The resignation follows his April appointment as a UBS Lumen nominee, signaling potential governance shifts. The move may affect investor sentiment and corporate governance dynamics at the Brazilian healthcare firm.